METOCLOPRAMIDE | METOCLOPRAMIDE | ATC A03FA01
METABOLISM ANTIEMETIC DOPAMINE ANTAGONISTS TREATMENT OF SYMPTOMATIC GASTROESOPHAGEAL REFLUX | ORAL INJECTION NASAL | Tmax 1.5 HOUR F 80 PERCENT VD 227.5 LITER (65 KILOGRAM) PPB 30 PERCENT Cl 22.2 LITER / HOUR (65 KILOGRAM) HT 5.5 HOUR SOLUBILITY FREELY SOLUBLE IN WATER | DOPAMINE RECEPTOR | DOPAMINE D2 RECEPTOR ANTAGONIST CHEMBL217 DOPAMINE D2 RECEPTOR P14416 D(2) DOPAMINE RECEPTOR HOMO SAPIENS MEMBRANE RECEPTOR 7TM1 SMALLMOL MONOAMINE RECEPTOR DOPAMINE RECEPTOR | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |